Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1037389 NEW YORK, NY
Back to JSPR Full portfolio

Position in JSPR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$100,155
-$55,335 QoQ
Shares Held
237,900
+34.0% QoQ
Ownership
0.715%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 44 holders
Holding Since
Mar 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JSPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. JSPR ranks #271 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in JSPR

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $100,155 237,900
2026-03-31 $155,490 177,500
2025-12-31 $415,744 227,183
2025-09-30 $496,230 208,500
2025-06-30 $57,720 10,400
2023-12-31 $405,801 514,324
2023-09-30 $217,148 310,212
2023-06-30 $79,597 58,100
2023-03-31 $199,462 110,200
2022-12-31 $31,588 65,400
2022-09-30 $22,565 28,600
2022-03-31 $38,592 10,871